The ingredient is also approved to claim as a health benefit that it “helps stimulate the growth of healthy bacteria (such as bifidobacteria) in the intestine/gut.”
Photo © AdobeStock.com/BillionPhotos.com
MSP Starch Products Inc. (MSP; Carberry, MB, Canada), announced that its resistant potato starch, Solnul, has secured Master File acceptance from Health Canada, allowing the ingredient to be sold as a prebiotic ingredient for Natural Health Products in the country. It is also approved to claim as a health benefit that it “helps stimulate the growth of healthy bacteria (such as bifidobacteria) in the intestine/gut.”
"This is a big win for resistant starch and for Canada. Getting Health Canada's approval is not just a great business achievement; it's also really meaningful to us,” stated chief growth officer of MSP Starch Products Inc., Jason Leibert, in a press release. “There's something special about selling right here at home, where we can directly support the health and well-being of Canadians while working toward our goal of bringing resistant starch back into modern diets.”
The ingredient is validated by a recent three-arm, randomized, double-blind, placebo-controlled clinical trial. The study found that consumption of 3.5 g per day of Solnul may produce a prebiotic effect. In the study, participants taking the resistant potato starch experienced significant changes in Bifidobacterium and Akkermansia after four weeks, compared to placebo.
Reference
HHS announces restructuring plans to consolidate divisions and downsize workforce
Published: March 27th 2025 | Updated: March 27th 2025According to the announcement, the restructuring will save taxpayers $1.8 billion per year by reducing the workforce by 10,000 full-time employees and consolidating the department’s 28 divisions into 15 new divisions.